Skip to main content

Table 5 Correlation between the change in endometrial thickness in both groups and different clinical variables

From: Metformin versus levonorgestrel-releasing intrauterine system in the management of endometrial hyperplasia: a randomized clinical trial

Variables

Δ ET in mirena

Δ ET in Metformin

r

p-value

R

p-value

Age

0.358

0.094a

0.425

0.043a

Menopausal years

0.015

0.95a

-0.029

0.933a

Parity

-0.486

0.019a

0.278

0.199a

BMI (kg/m2)

-0.064

0.773a

0.581

0.004a